<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Scholz T</dc:creator>
  <dc:creator>Hetzer FH</dc:creator>
  <dc:creator>Dindo D</dc:creator>
  <dc:creator>Demartines N</dc:creator>
  <dc:creator>Clavien PA</dc:creator>
  <dc:creator>Hahnloser D</dc:creator>
  <dc:date>2007</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">BACKGROUND AND AIMS
Chronic anal fissures are difficult to treat. The aim of this retrospective study was to determine the outcome of combined fissurectomy and injection of botulinum toxin Type A (BT).


MATERIALS AND METHODS
Between January 2001 and August 2004, 40 patients (21 women), median age 37 years (range 18 to 57), underwent fissurectomy and BT injection. Fissurectomy was performed followed by injection of 10 U of BT into the internal anal sphincter on both sides of the fissure. All patients were clinically checked 6 weeks after the operation. At 1 year, patients were sent a detailed questionnaire regarding symptoms, recurrence and further treatment for evaluation of long-term results.


RESULTS/FINDINGS
At 6 weeks, 38 patients (95%) were free of symptoms. No adverse effects were detected. The response rate of questionnaires was 93%; the median follow-up was 1 year (range 0.9 to 1.6). In the long-term, a recurrence was found in four patients. These patients were treated successfully with repeated fissurectomy and BT injections and salvage procedures, respectively. Overall, the success rate of combined fissurectomy and BT injection was 79%.


INTERPRETATION/CONCLUSION
Combined fissurectomy and Botox injection for chronic anal fissure is an excellent and safe procedure with low morbidity and a high healing rate.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/219561</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s00384-006-0261-z</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/17262202</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>International journal of colorectal disease. - 2007</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adolescent</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Botulinum Toxins, Type A</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Chronic Disease</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Drug Therapy, Combination</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Fissure in Ano</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Follow-Up Studies</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Neuromuscular Agents</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Retrospective Studies</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Treatment Outcome</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Wound Healing</dc:subject>
  <dc:title xmlns:ns16="xml" ns16:lang="en">Long-term follow-up after combined fissurectomy and Botox injection for chronic anal fissures.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
